Cargando…

Lower Platelet Aggregation Is a Risk Factor for Dual Antiplatelet Therapy-Associated Bleeding: A Preliminary Retrospective Study with Genotype Analysis

BACKGROUND: The purpose of this study was to investigate factors influencing bleeding in patients with acute coronary syndrome (ACS) who are on aspirin and ticagrelor as dual antiplatelet therapy. MATERIAL/METHODS: This retrospective case-control study included 50 patients with ACS (25 with reported...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Dongdong, Shi, Xiangfen, Guo, Liping, Wang, Gaobiao, Zhao, Yujie, Yang, Yuling, Zhang, Hanjuan, Huang, Qiong, Yuan, Yiqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2020
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318838/ https://www.ncbi.nlm.nih.gov/pubmed/32541641 http://dx.doi.org/10.12659/MSM.923758

Ejemplares similares

Identification of Potential Biological Factors Affecting the Treatment of Ticagrelor After Percutaneous Coronary Intervention in the Chinese Population
por: Yuan, Dongdong, et al.
Publicado: (2022)

Effects of colchicine on platelet aggregation in patients on dual antiplatelet therapy with aspirin and clopidogrel
por: Cirillo, Plinio, et al.
Publicado: (2020)

Dual Antiplatelet Therapy and the Severity Risk of Lower Intestinal Bleeding
por: Carlin, Neal, et al.
Publicado: (2017)

Antiplatelet Effects of Qishen Yiqi Dropping Pill in Platelets Aggregation in Hyperlipidemic Rabbits
por: Wang, Yi, et al.
Publicado: (2012)

Risk of bleeding in patients with continued dual antiplatelet therapy during orthopedic surgery
por: Hu, San-Bao, et al.
Publicado: (2019)

Platelet reactivity patterns in patients treated with dual antiplatelet therapy
por: Winter, Max‐Paul, et al.
Publicado: (2019)

Dual Antiplatelet Therapy (DAPT) versus No Antiplatelet Therapy and Incidence of Major Bleeding in Patients on Venoarterial Extracorporeal Membrane Oxygenation
por: Staudacher, Dawid L., et al.
Publicado: (2016)

CYP2C19 genotype and platelet aggregation test-guided dual antiplatelet therapy after off-pump coronary artery bypass grafting: A retrospective cohort study
por: Yao, Haoyi, et al.
Publicado: (2022)

Clinical Evaluation of Role of Dual Antiplatelet Therapy on Bleeding after Dental Extraction
por: Babaji, Prashant, et al.
Publicado: (2018)

Impact of bleeding during dual antiplatelet therapy in patients with coronary artery disease
por: Tung, Ying-Chang, et al.
Publicado: (2020)

Drug-Free Platelets Can Act as Seeds for Aggregate Formation During Antiplatelet Therapy
por: Hoefer, Thomas, et al.
Publicado: (2015)

Antiplatelet Agents Have a Distinct Efficacy on Platelet Aggregation Induced by Infectious Bacteria
por: Hannachi, Nadji, et al.
Publicado: (2020)

Antiplatelet protocol: Effects of ingesting a tomato pomace extract on human platelet aggregation
por: Concha-Meyer, Aníbal, et al.
Publicado: (2019)

BF066, a Novel Dual Target Antiplatelet Agent without Significant Bleeding
por: Pan, ChangE, et al.
Publicado: (2012)

Patient perspectives of nuisance bleeding and adherence to dual antiplatelet therapy: a qualitative study
por: Pithara, Christalla, et al.
Publicado: (2020)

Disaggregation Following Agonist-Induced Platelet Activation in Patients on Dual Antiplatelet Therapy
por: Wadowski, Patricia P., et al.
Publicado: (2017)

Characterization of a novel bifunctional mutant of staphylokinase with platelet-targeted thrombolysis and antiplatelet aggregation activities
por: Chen, Hongshan, et al.
Publicado: (2007)

Comparative evaluation of antiplatelet effect of lycopene with aspirin and the effect of their combination on platelet aggregation: An in vitro study
por: Sawardekar, Swapna B., et al.
Publicado: (2016)

Effects of Suilysin on Streptococcus suis-Induced Platelet Aggregation
por: Zhang, Shengwei, et al.
Publicado: (2016)

Dual antiplatelet therapy after percutaneous coronary intervention in patients at high bleeding risk: A systematic review and meta-analysis
por: Han, Yan, et al.
Publicado: (2023)

No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy
por: Laredo, Viviana, et al.
Publicado: (2020)

Dual Antiplatelet Therapy and Cancer; Balancing between Ischemic and Bleeding Risk: A Narrative Review
por: Tsigkas, Grigorios, et al.
Publicado: (2023)

Recurrent Non-Variceal Upper Gastrointestinal Bleeding among Patients Receiving Dual Antiplatelet Therapy
por: Yoo, Ah Young, et al.
Publicado: (2023)

Bleeding tendency in dual antiplatelet therapy with aspirin/clopidogrel: rescue of the template bleeding time in a single-center prospective study
por: Altman, Raul, et al.
Publicado: (2012)

Camel platelet aggregation responses and the antiplatelet effect of camel urine: comparison between black and white camels
por: Al-Ghumlas, Abeer Khalid
Publicado: (2020)

Novel Platelet Function Analyzer 200 Predicts Blood Transfusion After Elective Cardiac Surgery in Patients Suspended on Dual Antiplatelet Therapy
por: Cui, Wen, et al.
Publicado: (2023)

Effect of the Garlic Pill in comparison with Plavix on Platelet Aggregation and Bleeding Time
por: Fakhar, H, et al.
Publicado: (2012)

Anticoagulants/antiplatelets: Bleeding: 14 case reports
Publicado: (2020)

The impact of dual antiplatelet therapy administration on the risk of bleeding complications during coronary artery bypass surgery
por: Nardi, Paolo, et al.
Publicado: (2021)

Personalized Dual Antiplatelet Therapy in Acute Coronary Syndromes: Striking a Balance Between Bleeding and Thrombosis
por: Shpigelman, Jonathan, et al.
Publicado: (2023)

Platelets: Pathophysiology and Antiplatelet Drug Therapy
por: Snyder, Edward L.
Publicado: (1983)

Clinically relevant exaggerated pharmacodynamic response to dual antiplatelet therapy detected by Thromboelastogram(®) Platelet Mapping™
por: Hiller, Kenneth N.
Publicado: (2016)

Impact of Diabetes on Platelet Function in Acute Ischemic Stroke Patients Taking Dual Antiplatelet Therapy
por: Guo, Yinping, et al.
Publicado: (2021)

Inhibition of MCF-7 breast cancer cell-induced platelet aggregation using a combination of antiplatelet drugs
por: LIAN, LIAN, et al.
Publicado: (2013)

Antiplatelet Aggregation and Platelet Activating Factor (PAF) Receptor Antagonistic Activities of the Essential Oils of Five Goniothalamus Species
por: Moharam, Bushra Abdulkarim, et al.
Publicado: (2010)

Contractile forces in platelet aggregates under microfluidic shear gradients reflect platelet inhibition and bleeding risk
por: Ting, Lucas H., et al.
Publicado: (2019)

Performance of PRECISE-DAPT and Age–Bleeding–Organ Dysfunction Score for Predicting Bleeding Complication During Dual Antiplatelet Therapy in Chinese Elderly Patients
por: Dong, Liang, et al.
Publicado: (2022)

Risk Scores of Bleeding Complications in Patients on Dual Antiplatelet Therapy: How to Optimize Identification of Patients at Risk of Bleeding after Percutaneous Coronary Intervention
por: Pelliccia, Francesco, et al.
Publicado: (2022)

Retrospective analysis of the bleeding risk induced by oral antiplatelet drugs during radiotherapy
por: Xi, Dan, et al.
Publicado: (2021)

Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib
por: Kazianka, L, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_chnj5rgrqqe96t86f27rt8tn9k